History (1990-2022): Value through Innovation
Boehringer Ingelheim's secret recipe in a constantly changing healthcare market: creating value through innovation.
Search
Pioneering New Medicines Through External Innovation
On 22 November 2024 Boehringer Ingelheim hosted the event “Unleashing Innovation at Boehringer Ingelheim: Pioneering New Medicines Through External Innovation” at the Institute of Molecular Pathology (IMP)
Vision & Values
Vision & Values
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Boehringer Ingelheim Austria - Value through Innovation
Boehringer Ingelheim is one of the world's top 20 pharmaceutical companies with over 130 years of experience.
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
About Our Innovation Prize
Celebrating Our Innovation Prize Winners
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
How Boehringer Ingelheim is Supporting Grass Roots Innovation
Our Grass Roots activities support life-science innovators with mentoring and networking opportunities
Animal Health Innovation
Animal Health Innovation
Open Innovation Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
New cancer research building: Boosting innovation in oncology
With our new cancer research building in Vienna, we’ll advance our oncology pipeline and strengthen our commitment to innovation and collaboration.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Fostering innovation with partnerships and collaborations
Creating new and better medicines for patients. This commitment is driven by a strong belief in the power of collaboration.
Grass Roots
Grass Roots
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Human Health Innovation
Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Featured Stories
Featured Stories
Animal Health
Discover how Boehringer Ingelheim aims to ensure your companion pet gets the same level healthcare as people whether it be a normal house pet or horse.
Corporate Profile
Corporate Profile
Digital innovation: „We change the way labs work“
QUDA – an in-house software – changes the way labs work. It increases our quality assurance and our drug saftey.
More Health: Overview
As a company that operates at the intersection of human and veterinary medicine, we have unique opportunities to advocate for disadvantaged populations.